Methotrexate-induced pneumonitis in Crohn's disease: Case report and review of the literature

Multidisciplinary Respiratory Medicine

Volumn 5, Issue 5, 2010, Pages 312-319

  D'Andrea, Nadia ^a   Triolo, Luca ^a   Margagnoni, Giovanna ^a   Aratari, Annalisa ^a   Sanguinetti, Claudio M ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

Crohn's disease; CT; Methotrexate; Pneumonitis; Spirometry

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CLARITHROMYCIN; INFLIXIMAB; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; COUGHING; CROHN DISEASE; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FEVER; HUMAN; LUNG FUNCTION TEST; MAINTENANCE THERAPY; PANCREATITIS; PNEUMONIA; SUPRAVENTRICULAR TACHYCARDIA; THORAX RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; MULTIPLE CYCLE TREATMENT; SPIROMETRY;

EID: 78650198269     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-5-5-312     Document Type: Article

References (67)

1. Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2003;9:104-115. (Pubitemid 36367319)
2. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976;55:401-412.
3. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. III, Complications. Gut 1964;5:1-22.
4. Rogers BH, Clark LM, Kirsner JB. The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chronic Dis 1971;24:743-773.
5. Ford RM. Transient pulmonary eosinophilia and asthma. A review of 20 cases occurring in 5,702 asthma sufferers. Am Rev Resp Dis 1966;93:797-803.
6. Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Gillies R, Hopkins M, Hanauer SB, McDonald JW; for the North American Crohn's Study Group Investigators. Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995;332:292-297.
7. Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989;110:353-356.
8. Grove ML, Hassell AB, Hay EM, Shadforth MF. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. QJM 2001;94:309-319.
9. Schnabel A, Herlyn K, Burchardi C, Reinhold-Keller E, Gross WL. Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis. Rheumatol Int 1996;15:195-200.
10. Case records of the Massachussets General Hospital. Weekly clinicopathological excercises. Case 6-1985. Progressive pneumonitis after chemotherapy for breast carcinoma. N Engl J Med 1985;312:359-369.
11. Schwartz GF, Anderson ST. Methotrexate induced pneumonitis in a young woman with psoriasis and rheumatoid arthritis. J Rheumatol 1990;17:980.
12. Louie S, Lillington GA. Low dose methotrexate pneumonitis in rheumatoid arthritis. Thorax 1986;41:703-704.
13. Ridley MG, Wolfe CS, Mathews JA. Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature. Ann Rheum Dis 1988;47:784-788.
14. Barrera P, Laan RF, van Riel PL, Dekhuijzen PN, Boerbooms AM, van de Putte LB. Methotrexate-related pulmonary complications in rheumatoid arthritis. Ann Rheum Dis 1994;53:434-439.
15. Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000;15:373-381.
16. Brechmann T, Heyer C, Schmiegel W. Methotrexate-induced pneumonitis in a woman with Crohn's disease. Dtsch Med Wochenschr 2007;132:1759-1762.
17. Songür N, Songür Y, Tüzün M, Doǧan I, Tüzün D, Ensari A, Hekimoglu B. Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease. J Clin Gastoenterol 2003;37:292-298.
18. Mohamed-Hussein AA, Mohamed NA, Ibrahim ME. Changes in pulmonary function in patients with ulcerative colitis. Respir Med 2007;101:977-982.
19. Munck A, Murciano D, Pariente R, Cezard JP, Navarro J. Latent pulmonary function abnormalities in children with Crohn's disease. Eur Respir J 1995;8:377-380.
20. Herrlinger KR, Noftz MK, Dalhoff K, Ludwig D, Stange EF, Fellermann K. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol 2002;97:377-381.
21. Raj AA, Birring SS, Green R, Grant A, de Caestecker J, Pavord ID. Prevalence of inflammatory bowel disease in patients with airways disease. Respir Med 2008;102:780-785.
22. D'Andrea N, Vigliarolo R, Sanguinetti CM. Respiratory involvement in inflammatory bowel. Multidisciplinary Respiratory Medicine 2010;3:173-182.
23. Hsu PC, Lan JL, Hsieh TY, Jan YJ, Huang WN. Methotrexate pneumonitis in a patient with rheumatoid arthritis. J Microbiol Immunol Infect 2003;36:137-140.
24. Kremer JM, Alarcón GS, Weinblatt ME, Kaymakcian MV, Macaluso M, Cannon GW, Palmer WR, Sundy JS, St Clair EW, Alexander RW, Smith GJ, Axiotis CA. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum 1997;40:1829-1837.
25. Goodman TA, Polisson RP. Methotrexate: adverse reactions and major toxicities. Rheum Dis Clin North Am 1994;20:513-528.
26. Bannwarth B, Labat L, Moride Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis. An update. Drugs 1994;47:25-50.
27. Whittle SL, Hughes RA. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology 2004;43:267-271.
28. Rau R, Schleusser B, Herborn G, Karger T. Long-term treatment of destructive rheumatoid arthritis with methotrexate. J Rheumatol 1997;24:1881-1889.
29. Lateef O, Shakoor N, Balk RA. Methotrexate pulmonary toxicity. Expert Opin Drug Saf 2005;4:723-730.
30. Cannon GW. Methotrexate pulmonary toxicity. Rheum Dis Clin North Am 1997;23:917-937.
31. Kremer JM, Alarcón GS, Lighfoot RW Jr, Willkens RF, Furst DE, Williams HJ, Dent PB, Weinblatt ME. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 1994;37:316-328.
32. Kalantzis A, Marshman Z, Falconer DT, Morgan PR, Odell EW. Oral effects of low-dose methotrexate treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:52-62. (Pubitemid 40813391)
33. Rau R, Herborn G. Benefit and risk of methotrexate treatment in rheumatoid arthritis. Clin Exp Rheumatol 2004;22(5 Suppl 35):S83-S94.
34. Borchers AT, Keen CL, Cheema GS, Gershwin ME. The use of methotrexate in rheumatoid arthritis. Semin Arthritis Rheum 2004;34:465-483.
35. Hargreaves MR, Mowat AG, Benson MK. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports. Thorax 1992;47:628-633.
36. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease: Part 1: Cytotoxic drugs. Am Rev Respir Dis 1986;133:321-340. (Pubitemid 16123932)
37. Lynch JP 3rd, McCune WJ. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med 1997;155:395-420.
38. Hilliquin P, Renoux M, Perrot S, Puéchal X, Menkès CJ. Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis. Br J Rheumatol 1996;35:441-445. (Pubitemid 126719473)
39. IIkuni N, Iwami S, Kasai S, Tokuda H. Noncardiogenic pulmonary edema in low-dose oral methotrexate therapy. Intern Med 2004;43:846-851. (Pubitemid 39335114)
40. Walden PA, Mitchell-Weggs PF, Coppin C, Dent J, Bagshawe KD. Pleurisy and methotrexate treatment. Br Med J 1977;2:867.
41. nd Ed. New York, Thieme Medical Publisher, 1995;589-737.
42. LeMense GP, Sahn SA. Opportunistic infection during treatment with low dose methotrexate. Am J Respir Crit Care Med 1994;150:258-260. (Pubitemid 24209969)
43. Alarcón GS, Kremer JM, Macaluso M, Weinblatt ME, Cannon GW, Palmer WR, St Clair EW, Sundy JS, Alexander RW, Smith GJ, Axiotis CA. Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group. Ann Intern Med 1997;127:356-364.
44. Carson CW, Cannon GW, Egger MJ, Ward JR, Clegg DO. Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Semin Arthritis Rheum 1987;16:186-195. (Pubitemid 17029070)
45. Searles G, McKendry RJ. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and review of the literature. J Rheumatol 1987;14:1164-1171. (Pubitemid 18049936)
46. Golden MR, Katz RS, Balk RA, Golden HE. The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. J Rheumatol 1995;22:1043-1047.
47. Biederer J, Schnabel A, Muhle C, Gross WL, Heller M, Reuter M. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol 2004;14:272-280.
48. Padley SP, Adler B, Hansell DM, Müller NL. High-resolution computed tomography of drug-induced lung disease. Clin Radiol 1992;46:232-236.
49. Saravanan V, Kelly CA. Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis. Rheumatology 2004;43:143-147.
50. Jeurissen M, Boerbooms A, Festen J, van de Putte L, Doesburg W. Serial pulmonary function tests during randomized, double-blind trial of azathioprine versus methotrexate in rheumatoid arthritis. Arthritis Rheum 1991;34:S90.
51. Croock A, Furst D, Helmers R, et al. Methotrexate does not alter pulmonary function in patients with rheumatoid arthritis. Arthritis Rheum 1989;32:S60.
52. Velay B, Lamboley L, Massonnet B. Prospective study of respiratory function in rheumatoid arthritis treated with methotrexate. Eur Resp J 1988;1(S2):371S.
53. Beyeler C, Jordi B, Gerber NJ, Im Hof V. Pulmonary function in rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study. Br J Rheumatol 1996;35:446-452.
54. Leduc D, De Vuyst P, Lheureux P, Gevenois PA, Jacobovitz D, Yernault JC. Pneumonitis complicating low-dose methotrexate therapy for rheumatoid arthritis. Discrepancies between lung biopsy and bronchoalveolar lavage findings. Chest 1993;104:1620-1623.
55. Neves C, Jorge R, Barcelos A. A teia de toxicidade do methotrexato. Acta Reumatol Port 2009;34:11-34.
56. Elsasser S, Dalquen P, Soler M, Perruchoud AP. Methotrexate-induced pneumonitis: appearance four weeks after discontinuation of treatment. Am Rev Respir Dis 1989;140:1089-1092.
57. De Bandt M, Rat AC, Palazzo E, Kahn MF. Delayed methotrexate pneumonitis (letter). J Rheumatol 1991;18:1943.
58. St Clair EW, Rice JR, Snyderman R. Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis. Arch Intern Med 1985;145:2035-2038.
59. Hassell A, Dawes P. Serious problems with methotrexate? Br J Rheumatol 1994;33:1001-1002.
60. Carroll GJ, Thomas R, Phatouros CC, Atchison MH, Leslie AL, Cook NJ, D'Souza I. Incidence, prevalence and possible risk factors for pneumonitis with rheumatoid arthritis receiving methotrexate. J Rheumatol 1994;21:51-54.
61. Rosenow EC 3rd. Drug-induced pulmonary disease. Dis Mon 1994;40:253-310.
62. Cannon GW, Ward JR, Clegg DO, Samuelson CO Jr, Abbott TM. Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis. Arthritis Rheum 1983;26:1269-1274.
63. van der Veen MJ, Dekker JJ, Dinant HJ, van Soesbergen RM, Bijlsma JW. Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis. J Rheumatol 1995;22:1766-1768.
64. Sostman HD, Matthay RA, Putman CE, Smith GJ. Methotrexate-induced pneumonitis. Medicine (Baltimore) 1976;55:371-388.
65. Akoun GM, Gauthier-Rahman S, Mayaud CM, Touboul JL, Denis MF. Leucocyte migration inhibition in methotrexate-induced pneumonitis. Evidence for an immunologic cellmediated mechanism. Chest 1987;91:96-99.
66. Anderson LL, Collins GJ, Ojima Y, Sullivan RD. A study of the distribution of methotrexate in human tissues and tumors. Cancer Res 1970;30:1344-1348.
67. Green L, Schattner A, Berkenstadt H. Severe reversible interstitial pneumonitis induced by low dose methotrexate: report of a case and review of the literature. J Rheumatol 1988;15:110-112.